Biotech · Private company
OncoSec Medical Incorporated
Track this companyFree. Adds OncoSec Medical Incorporated to your Dealase workspace and tells you when its record changes.
Clinical trials100 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- gemcitabine plus carboplatinPhase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- ImmunopulsePhase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- ImmunoPulsePhase 2 · Stage III/IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- nab paclitaxelPhase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- OncoSec Medical System (OMS)Phase 2 · Merkel Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- OncoSec Medical System (OMS)Phase 2 · Cutaneous T Cell Lymphomas (CTCL)ClinicalTrials.gov · fetched Nov 12, 2026
- OncoSec Medical System (OMS)Phase 2 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- OncoSec Medical System (OMS)Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Stage III/IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- tavokinogene telseplasmidPhase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- tavokinogene telseplasmidPhase 2 · Stage III/IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Tavokinogene Telseplasmid (tavo)Phase 2 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Tavokinogene Telseplasmid (tavo)Phase 2 · Cutaneous T Cell Lymphomas (CTCL)ClinicalTrials.gov · fetched Nov 12, 2026
- Tavokinogene Telseplasmid (tavo)Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Tavokinogene Telseplasmid (tavo)Phase 2 · Merkel Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- IT-pIL12-EPPhase 1 · ER-Negative PR-Negative HER2-Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)PHASE1 · TERMINATED · started Dec 30, 2020ClinicalTrials.gov NCT04627675 · fetched Nov 12, 2026
- Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma PatientsPHASE2 · COMPLETED · started Dec 22, 2020ClinicalTrials.gov NCT04526730 · fetched Nov 12, 2026
- Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and EpacadostatPHASE2 · TERMINATED · started May 2, 2019ClinicalTrials.gov NCT03823131 · fetched Nov 12, 2026
- Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBCPHASE2 · UNKNOWN · started Oct 11, 2018ClinicalTrials.gov NCT03567720 · fetched Nov 12, 2026
- Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab TreatmentPHASE2 · UNKNOWN · started Oct 3, 2017ClinicalTrials.gov NCT03132675 · fetched Nov 12, 2026
- Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBCPHASE1 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02531425 · fetched Nov 12, 2026
- Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)PHASE2 · TERMINATED · started May 21, 2015ClinicalTrials.gov NCT02345330 · fetched Nov 12, 2026
- Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous LymphomaPHASE2 · TERMINATED · started Jun 8, 2012ClinicalTrials.gov NCT01579318 · fetched Nov 12, 2026
- Trial of pIL-12 Electroporation Malignant MelanomaPHASE2 · COMPLETED · started Feb 14, 2012ClinicalTrials.gov NCT01502293 · fetched Nov 12, 2026
- IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell CancerPHASE2 · COMPLETED · started Jan 3, 2012ClinicalTrials.gov NCT01440816 · fetched Nov 12, 2026